178 related articles for article (PubMed ID: 38253597)
41. [Distribution of HLA-DR antigens in unrelated giant cell arteritis].
Ninet J; Gebuhrer L; Bonvoisin B; Mackiewicz R; Laurent H; Boussuge C; Rousset H; Le Petit JC; Betuel H
Presse Med; 1987 Oct; 16(35):1725-8. PubMed ID: 2962084
[TBL] [Abstract][Full Text] [Related]
42. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population.
Huang HS; Peng JT; She JY; Zhang LP; Chao CC; Liu KH; She JX
Hum Immunol; 1995 Dec; 44(4):210-9. PubMed ID: 8770634
[TBL] [Abstract][Full Text] [Related]
43. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis.
Makki RF; al Sharif F; González-Gay MA; García-Porrúa C; Ollier WE; Hajeer AH
Clin Exp Rheumatol; 2000; 18(3):391-3. PubMed ID: 10895380
[TBL] [Abstract][Full Text] [Related]
44. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen.
Cid MC; Ercilla G; Vilaseca J; Sanmarti R; Villalta J; Ingelmo M; Urbano-Marquez A
Arthritis Rheum; 1988 May; 31(5):678-82. PubMed ID: 3259885
[TBL] [Abstract][Full Text] [Related]
45. Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8.
Hazleman B; Goldstone A; Voak D
Br Med J; 1977 Oct; 2(6093):989-91. PubMed ID: 922399
[TBL] [Abstract][Full Text] [Related]
46. Human leucocyte antigen class II DRB1 and DQB1 associations in human immunodeficiency virus-infected patients of Mumbai, India.
Shankarkumar U; Pawar A; Ghosh K; Bajpai S; Pazare A
Int J Immunogenet; 2010 Jun; 37(3):199-204. PubMed ID: 20345872
[TBL] [Abstract][Full Text] [Related]
47. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
48. Genetic and environmental factors in polymyalgia rheumatica.
Cimmino MA
Ann Rheum Dis; 1997 Oct; 56(10):576-7. PubMed ID: 9389216
[No Abstract] [Full Text] [Related]
49. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans.
Park YS; Wang CY; Ko KW; Yang SW; Park M; Yang MC; She JX
Hum Immunol; 1998 Dec; 59(12):794-801. PubMed ID: 9831135
[TBL] [Abstract][Full Text] [Related]
50. Effect of human leukocyte antigen class II genes on acute-onset and slow-onset type 1 diabetes in the Japanese population.
Katahira M; Segawa S; Maeda H; Yasuda Y
Hum Immunol; 2010 Aug; 71(8):789-94. PubMed ID: 20510319
[TBL] [Abstract][Full Text] [Related]
51. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.
Sato H; Woodhead FA; Ahmad T; Grutters JC; Spagnolo P; van den Bosch JM; Maier LA; Newman LS; Nagai S; Izumi T; Wells AU; du Bois RM; Welsh KI
Hum Mol Genet; 2010 Oct; 19(20):4100-11. PubMed ID: 20685690
[TBL] [Abstract][Full Text] [Related]
52. HLA DRB1/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study.
Lagha A; Messadi A; Boussaidi S; Kochbati S; Tazeghdenti A; Ghazouani E; Almawi WY; Yacoubi-Loueslati B
HLA; 2016 Sep; 88(3):100-9. PubMed ID: 27580864
[TBL] [Abstract][Full Text] [Related]
53. Association of HLA-DR with progressive systemic sclerosis in Japanese.
Takeuchi F; Nakano K; Yamada H; Hong GH; Nabeta H; Yoshida A; Matsuta K; Bannai M; Tokunaga K; Ito K
J Rheumatol; 1994 May; 21(5):857-63. PubMed ID: 8064726
[TBL] [Abstract][Full Text] [Related]
54. DNA typing of HLA class II genes in Japanese patients with dilated cardiomyopathy.
Nishi H; Koga Y; Koyanagi T; Harada H; Imaizumi T; Toshima H; Sasazuki T; Kimura A
J Mol Cell Cardiol; 1995 Oct; 27(10):2385-92. PubMed ID: 8576952
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 genotype with polymyalgia rheumatica.
Alvarez-Rodriguez L; Carrasco-Marin E; Lopez-Hoyos M; Mata C; Fernandez-Prieto L; Ruiz-Soto M; Calvo J; Rodriguez-Valverde V; Ruiz T; Blanco R; Corrales A; Martinez-Taboada VM
Hum Immunol; 2009 Jan; 70(1):49-54. PubMed ID: 19026700
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of polymyalgia rheumatica in a cohort of patients with idiopathic inflammatory myopathy.
Douglass-Molloy H; Limaye V
Clin Rheumatol; 2020 Apr; 39(4):1217-1221. PubMed ID: 31919772
[TBL] [Abstract][Full Text] [Related]
57. Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica.
Milchert M; Brzosko M
Rheumatol Int; 2020 Dec; 40(12):2071-2075. PubMed ID: 32683496
[TBL] [Abstract][Full Text] [Related]
58. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
59. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.
Arnett FC; Gourh P; Shete S; Ahn CW; Honey RE; Agarwal SK; Tan FK; McNearney T; Fischbach M; Fritzler MJ; Mayes MD; Reveille JD
Ann Rheum Dis; 2010 May; 69(5):822-7. PubMed ID: 19596691
[TBL] [Abstract][Full Text] [Related]
60. Comorbidities in polymyalgia rheumatica: a systematic review.
Partington R; Helliwell T; Muller S; Abdul Sultan A; Mallen C
Arthritis Res Ther; 2018 Nov; 20(1):258. PubMed ID: 30458857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
